Candel Therapeutics, Inc. (CADL) Insider Trading

Name: Candel Therapeutics, Inc. (CADL) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Loggia Nicoletta (Director): Grant/Award of 380 shares, $3.3K.

Get alerted when insiders trade CADL

Email address

Loading company data...

Beta

Loading company details...

Beta